• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与轮状病毒疾病防护相关的宿主因素:曙光渐现。

Host factors associated with protection against rotavirus disease: the skies are clearing.

作者信息

Offit P A

机构信息

Children's Hospital of Philadelphia, Pennsylvania, USA.

出版信息

J Infect Dis. 1996 Sep;174 Suppl 1:S59-64. doi: 10.1093/infdis/174.supplement_1.s59.

DOI:10.1093/infdis/174.supplement_1.s59
PMID:8752292
Abstract

Over the past several years, a number of studies have clarified aspects of rotavirus immunology and vaccinology previously considered controversial. In this review, studies that address the following questions will be summarized: Which host factors are responsible for recovery from acute rotavirus infection? Are the host factors responsible for recovery from acute infection the same as those necessary for prevention of infection? What is the relative importance of the nature of the inoculum (e.g., homologous or heterologous host virus and live or inactivated virus), route of inoculation, or virus serotype in vaccine development? What is the immunologic basis by which infection with 1 viral serotype protects against challenge with another serotype (heterotypic protection)?

摘要

在过去几年中,一些研究阐明了轮状病毒免疫学和疫苗学中以前被认为有争议的方面。在本综述中,将总结针对以下问题的研究:哪些宿主因素负责从急性轮状病毒感染中恢复?负责从急性感染中恢复的宿主因素与预防感染所需的因素相同吗?接种物的性质(例如,同源或异源宿主病毒以及活病毒或灭活病毒)、接种途径或病毒血清型在疫苗开发中的相对重要性是什么?感染一种病毒血清型可预防另一种血清型攻击(异型保护)的免疫学基础是什么?

相似文献

1
Host factors associated with protection against rotavirus disease: the skies are clearing.与轮状病毒疾病防护相关的宿主因素:曙光渐现。
J Infect Dis. 1996 Sep;174 Suppl 1:S59-64. doi: 10.1093/infdis/174.supplement_1.s59.
2
Mechanisms of protection against rotavirus in humans and mice.人类和小鼠中针对轮状病毒的保护机制。
J Infect Dis. 1996 Sep;174 Suppl 1:S51-8. doi: 10.1093/infdis/174.supplement_1.s51.
3
Induction of mucosal B-cell memory by intramuscular inoculation of mice with rotavirus.通过给小鼠肌肉注射轮状病毒诱导黏膜B细胞记忆
J Virol. 1998 Apr;72(4):3479-83. doi: 10.1128/JVI.72.4.3479-3483.1998.
4
Protective effects of natural rotavirus infection.自然轮状病毒感染的保护作用。
Pediatr Infect Dis J. 2009 Mar;28(3 Suppl):S54-6. doi: 10.1097/INF.0b013e3181967c03.
5
Review of rotavirus vaccine trials in Finland.
J Infect Dis. 1996 Sep;174 Suppl 1:S81-7. doi: 10.1093/infdis/174.supplement_1.s81.
6
Rotavirus serotypes: classification and importance in epidemiology, immunity, and vaccine development.轮状病毒血清型:在流行病学、免疫和疫苗研发中的分类及重要性
J Health Popul Nutr. 2000 Jun;18(1):5-14.
7
Immune responses and protection obtained by oral immunization with rotavirus VP4 and VP7 DNA vaccines encapsulated in microparticles.用包裹在微粒中的轮状病毒VP4和VP7 DNA疫苗进行口服免疫所获得的免疫反应和保护作用。
Virology. 1999 Jun 20;259(1):148-53. doi: 10.1006/viro.1999.9751.
8
Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection.用轮状病毒样颗粒进行直肠免疫可诱导全身和黏膜体液免疫反应,并保护小鼠免受轮状病毒感染。
J Virol. 2006 Feb;80(4):1752-61. doi: 10.1128/JVI.80.4.1752-1761.2006.
9
Field trial of rhesus rotavirus or human-rhesus rotavirus reassortant vaccine of VP7 serotype 3 or 1 specificity in infants. The Elmwood, Panorama, and Westfall Pediatric Groups.3型或1型VP7血清型恒河猴轮状病毒或人-恒河猴轮状病毒重配疫苗在婴儿中的现场试验。埃尔姆伍德、全景和韦斯特福尔儿科研究组。
J Infect Dis. 1992 Aug;166(2):235-43. doi: 10.1093/infdis/166.2.235.
10
Protection against rotavirus disease after natural rotavirus infection. US Rotavirus Vaccine Efficacy Group.
J Infect Dis. 1994 Apr;169(4):900-4. doi: 10.1093/infdis/169.4.900.

引用本文的文献

1
In Vivo Evaluation of Immune-Enhancing Activity of Red Gamju Fermented by Probiotic KU15154 in Mice.益生菌KU15154发酵的红甘酒对小鼠免疫增强活性的体内评价
Foods. 2021 Jan 26;10(2):253. doi: 10.3390/foods10020253.
2
I, 1.Viral causes of gastroenteritis.一、1. 病毒性肠胃炎的病因
Perspect Med Virol. 2003;9:9-21. doi: 10.1016/S0168-7069(03)09002-5. Epub 2004 Sep 14.
3
Literature Review on Rotavirus: Disease and Vaccine Characteristics: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).
轮状病毒文献综述:疾病与疫苗特性:一份咨询委员会声明(ACS) 国家免疫咨询委员会(NACI)
Can Commun Dis Rep. 2010 Nov 30;36(ACS-14):1-31. doi: 10.14745/ccdr.v36i00a14.
4
Epidemiological Survey of Rotaviruses Responsible for Infantile Diarrhea by the Immunomolecular Technique in Cotonou (Benin, West Africa).在科托努(西非贝宁)采用免疫分子技术对引起婴儿腹泻的轮状病毒进行的流行病学调查。
Int J Microbiol. 2018 May 8;2018:3602967. doi: 10.1155/2018/3602967. eCollection 2018.
5
[Epidemiological and clinical study of rotavirus acute diarrhea in infants at the hospital Jason Sendwe Lubumbashi, Democratic Republic of Congo].[刚果民主共和国卢本巴希杰森·森德韦医院婴幼儿轮状病毒急性腹泻的流行病学与临床研究]
Pan Afr Med J. 2015 Jun 10;21:113. doi: 10.11604/pamj.2015.21.113.5737. eCollection 2015.
6
Construction and characterization of human rotavirus recombinant VP8* subunit parenteral vaccine candidates.构建并鉴定人轮状病毒重组 VP8*亚单位肠道外疫苗候选株。
Vaccine. 2012 Sep 21;30(43):6121-6. doi: 10.1016/j.vaccine.2012.07.078. Epub 2012 Aug 9.
7
Epidemiology of rotavirus infection among young children with acute diarrhoea in Burkina Faso.布基纳法索急性腹泻病幼儿轮状病毒感染的流行病学。
BMC Pediatr. 2010 Dec 20;10:94. doi: 10.1186/1471-2431-10-94.
8
Non-structural protein NSP2 induces heterotypic antibody responses during primary rotavirus infection and reinfection in children.非结构蛋白NSP2在儿童初次轮状病毒感染和再感染期间诱导异型抗体反应。
J Med Virol. 2008 Jun;80(6):1090-8. doi: 10.1002/jmv.21160.
9
Heterogeneity and temporal dynamics of evolution of G1 human rotaviruses in a settled population.定居人群中G1型人类轮状病毒进化的异质性和时间动态
J Virol. 2006 Nov;80(21):10724-33. doi: 10.1128/JVI.00340-06. Epub 2006 Aug 23.
10
Selection of single-chain antibodies against the VP8* subunit of rotavirus VP4 outer capsid protein and their expression in Lactobacillus casei.抗轮状病毒VP4外衣壳蛋白VP8*亚基单链抗体的筛选及其在干酪乳杆菌中的表达
Appl Environ Microbiol. 2004 Nov;70(11):6936-9. doi: 10.1128/AEM.70.11.6936-6939.2004.